FDC Stock Screener | Share Price & Fundamental Analysis
FDC
Pharmaceuticals
Share Price NSE
₹368.90
▼
-7.65 (-2.03%)
Share Price BSE
₹368.55
▼
-7.00 (-1.86%)
Track FDC share price live with TickJournal's free stock screener.
Analyze FDC share price history trends and compare 52-week high low
levels.
Calculate FDC stock fair value using fundamental analysis and view live share price charts.
Determine FDC share intrinsic value and compare it with current FDC share price.
Record your FDC trades in TickJournal's free trading journal and track your portfolio performance.
FDC Market Cap
₹6,126.54 Cr.
FDC P/E Ratio (TTM)
29.15
FDC P/B Ratio
2.60
EPS (TTM)
₹16.39
Dividend Yield
1.29%
Debt to Equity
0.01
FDC 52 Week High
₹509.70
FDC 52 Week Low
₹363.40
Operating Margin
7.00%
Profit Margin
5.76%
FDC Revenue (TTM)
₹486.00
EBITDA
₹52.00
Net Income
₹28.00
Total Assets
₹2,714.00
Total Equity
₹2,281.00
FDC Share Price History - Stock Screener Chart
Screen FDC historical share price movements with interactive charts. Analyze price trends and patterns.
FDC Company Profile - Fundamental Screener
Screen FDC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for FDC shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE258B01022
FDC Balance Sheet Screener
Screen FDC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,714 | 2,468 | 2,343 | 2,270 | 1,956 | 1,813 | 1,640 | 1,505 | 1,468 | 1,266 |
| Current Assets | 1,089 | 1,067 | 1,027 | 1,000 | 934 | 927 | 740 | 722 | 708 | 523 |
| Fixed Assets | 852 | 680 | 699 | 705 | 689 | 674 | 682 | 674 | 678 | 675 |
| Liabilities | ||||||||||
| Total Liabilities | 2,714 | 2,468 | 2,343 | 2,270 | 1,956 | 1,813 | 1,640 | 1,505 | 1,468 | 1,266 |
| Current Liabilities | 71 | 60 | 50 | 42 | 19 | 19 | 16 | 18 | 18 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,281 | 2,097 | 1,981 | 1,956 | 1,734 | 1,547 | 1,445 | 1,276 | 1,270 | 1,083 |
| Share Capital | 16 | 16 | 17 | 17 | 17 | 17 | 18 | 18 | 18 | 18 |
| Reserves & Surplus | 2,265 | 2,081 | 1,966 | 1,940 | 1,717 | 1,530 | 1,428 | 1,259 | 1,252 | 1,065 |
FDC Income Statement Screener - Profit & Revenue Analysis
Screen FDC income statement and profit fundamentals.
Analyze FDC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for FDC share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 486 | 494 | 684 | 508 | 483 | 549 | 667 | 482 | 483 | 514 | 566 | 442 | 428 | 458 | 514 |
| Expenses | 433 | 439 | 508 | 438 | 418 | 444 | 492 | 406 | 374 | 410 | 414 | 386 | 360 | 378 | 417 |
| EBITDA | 52 | 54 | 176 | 70 | 66 | 105 | 175 | 77 | 109 | 104 | 151 | 56 | 68 | 80 | 97 |
| Operating Profit % | 7.00% | 7.00% | 22.00% | 11.00% | 10.00% | 14.00% | 23.00% | 12.00% | 18.00% | 16.00% | 23.00% | 11.00% | 12.00% | 15.00% | 16.00% |
| Depreciation | 15 | 15 | 15 | 16 | 13 | 14 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 36 | 38 | 160 | 53 | 51 | 90 | 163 | 65 | 98 | 93 | 141 | 45 | 57 | 69 | 87 |
| Tax | 8 | 10 | 38 | 15 | 14 | 18 | 44 | 19 | 18 | 23 | 31 | 15 | 16 | 17 | 16 |
| Net Profit | 28 | 28 | 121 | 39 | 37 | 72 | 119 | 46 | 79 | 70 | 110 | 31 | 41 | 52 | 71 |
| EPS | 1.74 | 1.75 | 7.45 | 2.38 | 2.28 | 4.43 | 7.31 | 2.84 | 4.86 | 4.22 | 6.62 | 1.85 | 2.45 | 3.10 | 4.23 |
FDC Cash Flow Screener - Liquidity Fundamentals
Screen FDC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 318 | 221 | 155 | 162 | 207 | 250 | 112 | 150 | 155 | 174 |
| Investing Activities | -199 | -17 | 11 | -145 | -77 | -98 | -121 | 21 | -144 | -73 |
| Financing Activities | -92 | -202 | -180 | -10 | -129 | -142 | 0 | -169 | 0 | -97 |
| Net Cash Flow | 26 | 2 | -14 | 7 | 1 | 10 | -8 | 1 | 11 | 4 |
FDC Shareholding Pattern Screener
See FDC shareholding pattern with promoter, FII, and DII holdings.
Check FDC promoter holding and ownership changes for FDC on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% |
| FII Holding | 2.55% | 2.41% | 2.43% | 2.32% | 2.65% | 2.51% | 2.62% | 2.67% |
| DII Holding | 6.37% | 7.17% | 6.82% | 6.27% | 6.94% | 6.73% | 6.03% | 6.08% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.22% | 16.17% | 16.40% | 16.97% | 16.54% | 16.71% | 16.70% | 16.57% |
| Other Holding | 5.20% | 4.59% | 4.70% | 4.78% | 4.22% | 4.39% | 5.00% | 5.02% |
| Shareholder Count | 53,880 | 54,445 | 54,157 | 53,788 | 52,377 | 50,634 | 55,400 | 55,228 |
FDC Share Dividend Screener - Share Yield Analysis
Check FDC dividend history with payout and yield data.
View FDC dividend details including ex-dates and amounts for FDC stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.00 | 1.33% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.80 | 0.28% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹2.25 | 0.90% |
FDC Stock Index Membership
See which indices include FDC stock.
Check FDC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
FDC Market Events Screener - Corporate Actions
Get FDC corporate actions including splits, bonuses, and buybacks.
Check FDC stock events that may affect FDC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.36% | ||
| Annual General Meeting | NA | -0.85% | ||
| Annual General Meeting | NA | -0.22% | ||
| 2026-02-11 | 2026-02-11 | Dividend | ₹ 5.00 /share | 2.66% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 3.96% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 3.59% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -0.64% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.68% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.50% |
| 2024-11-22 | 2024-11-22 | Dividend | ₹ 5.00 /share | -10.27% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | 4.71% |
| 2023-08-25 | 2023-08-31 | Buyback | 500 | 1.40% |
FDC Competitors Screener - Peer Comparison
Screen FDC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
FDC Company Announcements - News Screener
Screen FDC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-18 | Disclosure Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-13 | Record Date For Interim Dividend | View |
| 2026-02-13 | Corporate Action-Board approves Dividend | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2026-01-30 | Update on board meeting | View |
| 2026-01-29 | Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For Quarter And Nine Month Ended On December 31 2025 | View |
| 2026-01-28 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-01-28 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2026-01-09 | Announcement Under Regulation 30 (LODR) - ANDA Approval | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-29 | Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 | View |
| 2025-12-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-24 | Closure of Trading Window | View |
| 2025-12-24 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Change in Registered Office Address | View |
| 2025-12-08 | Intimation Of Companys New Correspondence Address | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-05 | Board Meeting Outcome for Outcome For The Board Meeting Held On November 05 2025. | View |
| 2025-10-28 | Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results For Quarter And Half Year Ended On September 30 2025 | View |